These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38489246)

  • 1. Identification of Dihydrobenzofuran Neolignans as Novel PDE4 Inhibitors and Evaluation of Antiatopic Dermatitis Efficacy in DNCB-Induced Mice Model.
    Gu C; Liu J; Qian F; Yu W; Huang D; Shen J; Feng C; Chen K; Li Y; Jiang X; Xu Y; Zhang L
    J Med Chem; 2024 Mar; 67(6):4855-4869. PubMed ID: 38489246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological Profile of Difamilast, a Novel Selective Phosphodiesterase 4 Inhibitor, for Topical Treatment of Atopic Dermatitis.
    Hiyama H; Arichika N; Okada M; Koyama N; Tahara T; Haruta J
    J Pharmacol Exp Ther; 2023 Jul; 386(1):45-55. PubMed ID: 37041087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-inflammatory effects of a novel phosphodiesterase-4 inhibitor, AA6216, in mouse dermatitis models.
    Kubota-Ishida N; Matsuhira T; Kaji C; Kikuchi C; Tabata Y
    Eur J Pharmacol; 2021 Sep; 906():174258. PubMed ID: 34139195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Skin Inflammation with Benzoxaborole Phosphodiesterase Inhibitors: Selectivity, Cellular Activity, and Effect on Cytokines Associated with Skin Inflammation and Skin Architecture Changes.
    Dong C; Virtucio C; Zemska O; Baltazar G; Zhou Y; Baia D; Jones-Iatauro S; Sexton H; Martin S; Dee J; Mak Y; Meewan M; Rock F; Akama T; Jarnagin K
    J Pharmacol Exp Ther; 2016 Sep; 358(3):413-22. PubMed ID: 27353073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, and biological evaluation of novel catecholopyrimidine based PDE4 inhibitor for the treatment of atopic dermatitis.
    Purushothaman B; Arumugam P; Kulsi G; Song JM
    Eur J Med Chem; 2018 Feb; 145():673-690. PubMed ID: 29353721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ME3183, a novel phosphodiesterase-4 inhibitor, exhibits potent anti-inflammatory effects and is well tolerated in a non-clinical study.
    Kubota-Ishida N; Kaji C; Matsumoto S; Wakabayashi T; Matsuhira T; Okura I; Cho N; Isshiki S; Kumura K; Tabata Y
    Eur J Pharmacol; 2024 Jan; 962():176202. PubMed ID: 37996010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Honokiol suppresses 2,6-dinitrochlorobenzene-induced atopic dermatitis in mice.
    Lee JH; Im DS
    J Ethnopharmacol; 2022 May; 289():115023. PubMed ID: 35074454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical effects of roflumilast on 1-chloro-2,4-dinitrobenzene-induced atopic dermatitis-like skin lesions in NC/Nga mice.
    Heo JY; Cho YS; Cheon HG
    Pharmazie; 2010 Dec; 65(12):906-12. PubMed ID: 21284261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antipruritic effect of the topical phosphodiesterase 4 inhibitor E6005 ameliorates skin lesions in a mouse atopic dermatitis model.
    Ishii N; Shirato M; Wakita H; Miyazaki K; Takase Y; Asano O; Kusano K; Yamamoto E; Inoue C; Hishinuma I
    J Pharmacol Exp Ther; 2013 Jul; 346(1):105-12. PubMed ID: 23674603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery and Structural Optimization of Toddacoumalone Derivatives as Novel PDE4 Inhibitors for the Topical Treatment of Psoriasis.
    Song Z; Huang YY; Hou KQ; Liu L; Zhou F; Huang Y; Wan G; Luo HB; Xiong XF
    J Med Chem; 2022 Mar; 65(5):4238-4254. PubMed ID: 35188767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of mineral complex material treatment on 2,4- dinitrochlorobenzene-induced atopic dermatitis like-skin lesions in mice model.
    Bajgai J; Xingyu J; Fadriquela A; Begum R; Kim DH; Kim CS; Kim SK; Lee KJ
    BMC Complement Med Ther; 2021 Mar; 21(1):82. PubMed ID: 33658026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 7,8,4'-Trihydroxyisoflavone attenuates DNCB-induced atopic dermatitis-like symptoms in NC/Nga mice.
    Kim H; Kim JR; Kang H; Choi J; Yang H; Lee P; Kim J; Lee KW
    PLoS One; 2014; 9(8):e104938. PubMed ID: 25170825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exosomes derived from human dermal fibroblasts (HDFn-Ex) alleviate DNCB-induced atopic dermatitis (AD) via PPARα.
    Jang YN; Lee JO; Lee JM; Park AY; Kim YJ; Kim SY; Seok J; Yoo KH; Kim BJ
    Exp Dermatol; 2024 Jan; 33(1):e14970. PubMed ID: 37975541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical E6005, a novel phosphodiesterase 4 inhibitor, attenuates spontaneous itch-related responses in mice with chronic atopy-like dermatitis.
    Andoh T; Yoshida T; Kuraishi Y
    Exp Dermatol; 2014 May; 23(5):359-61. PubMed ID: 24645735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-atopic effect of Viola yedoensis ethanol extract against 2,4-dinitrochlorobenzene-induced atopic dermatitis-like skin dysfunction.
    Fan P; Yang Y; Liu T; Lu X; Huang H; Chen L; Kuang Y
    J Ethnopharmacol; 2021 Nov; 280():114474. PubMed ID: 34332065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apremilast Normalizes Gene Expression of Inflammatory Mediators in Human Keratinocytes and Reduces Antigen-Induced Atopic Dermatitis in Mice.
    Schafer PH; Adams M; Horan G; Truzzi F; Marconi A; Pincelli C
    Drugs R D; 2019 Dec; 19(4):329-338. PubMed ID: 31598889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polygonum perfoliatum L. ethanol extract ameliorates 2,4-dinitrochlorobenzene-induced atopic dermatitis-like skin inflammation.
    Fan P; Xie S; Zhang Z; Yuan Q; He J; Zhang J; Liu X; Liu X; Xu L
    J Ethnopharmacol; 2024 Jan; 319(Pt 2):117288. PubMed ID: 37827300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cynanchum atratum inhibits the development of atopic dermatitis in 2,4-dinitrochlorobenzene-induced mice.
    Choi YY; Kim MH; Lee H; Ahn KS; Um JY; Lee SG; Kim J; Yang WM
    Biomed Pharmacother; 2017 Jun; 90():321-327. PubMed ID: 28365521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Artemisia annua water extract attenuates DNCB-induced atopic dermatitis by restraining Th2 cell mediated inflammatory responses in BALB/c mice.
    Han X; Chen Z; Yuan J; Wang G; Han X; Wu H; Shi H; Chou G; Yang L; Wu X
    J Ethnopharmacol; 2022 Jun; 291():115160. PubMed ID: 35245629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. D-Mannose ameliorates DNCB-induced atopic dermatitis in mice and TNF-α-induced inflammation in human keratinocytes via mTOR/NF-κB pathway.
    Luo J; Li Y; Zhai Y; Liu Y; Zeng J; Wang D; Li L; Zhu Z; Chang B; Deng F; Zhang J; Zhou J; Sun L
    Int Immunopharmacol; 2022 Dec; 113(Pt A):109378. PubMed ID: 36327873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.